Vietnam Pharmaceutical Commercial Consulting

YCP seamlessly integrates global insights with local expertise, driving success in Vietnam’s pharmaceutical sector. Discover how our collaborative approach and decades of experience help you navigate Vietnam’s competitive market, offering comprehensive consulting that benefits your commercial strategy.

Vietnam Pharmaceutical Commercial Consulting

YCP in Numbers

YCP Holdings
Project Across Asia
Offices
Portfolio Businesses
Professionals
0

Vietnam's pharma market is forecasted to grow at an impressive rate of

8.1%*

over the next five years, making it a high-potential landscape for investors.

Source: Vietnam Ministry of Health, 2024

YCP Pharmaceutical Commercial Experts in Vietnam

The pharmaceutical industry in Vietnam is experiencing significant growth, driven by rapid advancements and developments in various sectors. As the country steadily emerges as an integral player in this realm, the pharmaceutical sector thrives amidst these burgeoning innovations. This surge in progress paints a promising overview for the Vietnam Pharmaceutical Commercial Consulting landscape.

YCP's global professionals, equipped with extensive expertise and a profound understanding of the pharmaceutical commercial space, deliver unparalleled consulting solutions. Our services have consistently assisted clients in overcoming market barriers and facilitating successful market entry and growth within Vietnam's vibrant industry. Such empirical insights uniquely position YCP at the forefront of pharmaceutical commercial breakthroughs.

Trusted as a premier partner, YCP offers business leaders unparalleled insights for thriving within Vietnam's pharmaceutical market. Our expertise, combined with strategic prowess, fortifies our clients' competitive stance, making us a distinguished pharmaceutical commercial ally.

Unlocking Potential: Your Path to Excellence with Vietnam's Pharmaceutical Commercial Professionals

Strategic Account Planning

Pricing Insights

GTM Strategy

Our Services

Digital Transformation

Pioneering Vietnam's pharmaceutical landscape by aligning your commercial strategy with digital advancements.

  • Digital Roadmap & DX Strategy
  • DX Maturity Assessment
  • CIO/CDO Advisory & IT Organization Design
  • System Architecture & IT Portfolio Management
  • AI, RPA & Intelligent Process Automation
  • Big Data & Analytics
  • Data Governance & Digital Adoption
  • Offshore Development Centre Set-up

Market Research

Navigate Vietnam's pharmaceutical market complexities with tailored insights and strategic consultancy.

  • Market Landscape
  • Market Size
  • Industry Structure and Trend
  • Competitive Benchmark
  • Business Partner Search & Screening
  • B2B/B2C Customer Survey
  • Consumer Research

Marketing & Sales

Optimizing pharmaceutical market entry strategies and sales in Vietnam with revenue-driven expertise.

  • Branding & Brand Management
  • Product & Portfolio Management
  • Pricing
  • Digital Marketing
  • E-commerce
  • Customer Experience
  • Sales Channel Strategy
  • Digital Sales
  • Lead Generation and Nurturing
  • Content Marketing

M&A, Transactions, and PMI

Through in-depth analysis and strategic advisory, YCP facilitates seamless M&A, transactions, and PMI in Vietnam's dynamic pharmaceutical sector.

  • M&A Strategy & Deal Sourcing
  • Buy-Side & Sell-Side Advisory
  • Cross-border M&A Advisory
  • Commercial Due Diligence & Valuation
  • Divestiture & Carve-out Strategy
  • Post-Merger Integration (PMI) & Value Creation
  • Joint Venture
  • Corporate Venture Capital & IPO

Operations

Leverage local insights to optimize pharmaceutical operations, boosting competitiveness in Vietnam.

  • Project Management Office (PMO)
  • Growth Strategy Implementation
  • Operation Transformation
  • Manufacturing
  • Organization Design

Public Services

Leverage YCP’s market insights in Vietnam's pharmaceutical sector to optimize commercial strategies.

  • Economic Development
  • Public Policy Development
  • E-Governance

Strategy

Utilize data-driven insights to refine market entry tactics for optimal pharmaceutical growth in Vietnam.

  • Corporate & Business Strategy
  • Growth Strategy & Market Entry
  • Business Plan & Mid-Term Management Plan
  • Competitive Landscape & Value Chain Analysis
  • New Business Development & Feasibility Study
  • Strategic Partnership & Channel Strategy
  • Organization Strategy & Change Management
  • Enterprise & Asset Risk Management
  • Strategy Execution Support & Business Turnaround
  • Digital Strategy

Supply Chain Management

Optimize distribution strategies in Vietnam’s pharmaceutical sector for seamless business growth.

  • Supply Chain
  • Digital Supply Chain
  • Procurement
  • Logistics

Sustainability

Navigating sustainability: strategic solutions for greening Vietnam's pharmaceutical landscape.

  • Sustainability Strategy & Implementation
  • Double Materiality
  • Decarbonization & Net-Zero Strategy
  • Climate Change Risks and Opportunities
  • Sustainability Due Diligence
  • Supply Chain Assessment
  • ESG Reporting
  • Investor Relations & Fundraising
  • Organization & Governance Design

Navigating Pharmaceutical Commercial Sector in Vietnam

Regulatory Challenges In The Vietnamese Pharma Sector

  • Vietnam's regulatory framework for the pharmaceutical industry is complex, with bureaucratic barriers estimated to reduce market entry probability by over 10%.
  • Despite these challenges, involving technology could streamline compliance, as market is expected to grow by 12% annually, driven by increasing domestic health investment.

Inefficient Distribution Systems In Vietnam's Pharma

  • Over 20% of domestically produced pharmaceuticals in Vietnam experience logistical delays due to unreliable distribution channels and outdated storage facilities.
  • By optimizing distribution through digital tracking, imports and exports could reduce losses significantly, fetching a market expansion by as much as 15%.

Rising Demand In Vietnam's Pharma Market

  • Vietnam's pharmaceutical spending per capita projected to reach $164 by 2024 highlights increasing consumer demand due to an ageing population.
  • Capitalizing on this demand, companies can drive growth with innovative therapeutic solutions, leveraging unmet healthcare needs among trend-conscious consumers.

Government Initiatives Promoting Pharma Growth

  • The Vietnamese government targets the pharmaceutical sector for aggressive growth, motivating $790 million investments in local manufacturing and research facilities by 2025.
  • Boosting domestic production and investing in R&D can position companies favorably in an industry expected to increase by 8% through tech collaboration.

Our Clients

We have worked with more than 2000 companies throughout various industries.

0
1
2
3
4
5
6
7
8
9
10
11

What Our Clients Say About Us

"The systematic and detailed approach adopted by the YCP team has helped to provide an in-depth analysis of the specific businesses in the country we are interested to enter. Their findings and recommendations have helped us gain a better understanding and make strategic decisions on our business expansion plan in this specific emerging country. I am therefore happy to recommend YCP as a reliable partner to any company requiring research and consulting capabilities in the medical areas. "

Boston Scientific Asia Pacific

Channels Manager ASEAN

Boston Scientific Asia Pacific

"YCP made sure they had a thorough understanding of our business needs and objectives and focused on the key aspects of the Vietnam market that helped us with our market development strategies. Their analysis and recommendations provided us with clear insights into the decision of our strategic options. "

Teva Pharma

Managing Director Asia Pacific

Teva Pharma

Results Through Expertise: Case Studies

Learn how we help clients build and implement strategies
that drive sustainable growth in today’s complex business landscape.

Corporate Entity Restructuring Advisory and M&A Target Search

Client

Fortune 500 MNC leader in medical imaging

Area

Indonesia

Expertise Scope

Mergers & Acquisition PMO

Project Summary

Amid the parent company's restructuring, our client sought YCP's expertise in re-entry strategy and M&A target identification. With our in-depth analysis, we negotiated with two M&A targets for 100% acquisition, saving over EUR 100M in investments.

E-Commerce Website Development

Client

A Japanese medical equipment manufacturer

Area

Southeast Asia

Expertise Scope

Strategic Marketing

Project Summary

Our client needed support tapping into the Southeast Asian market and building an e-commerce channel.​ We created a market entry strategy in three countries, developed localised landing pages, and managed client campaigns to gain market access.

YCP in Media

Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Our Group CEO Yuki Ishida and Managing Partner Karambir Anand shared insights at the ASEAN–Japan Young Business Leaders’ Summit.

Our Group CEO Yuki Ishida and Managing Partner Karambir Anand shared insights at the ASEAN–Japan Young Business Leaders’ Summit.

At the Asian Power Summit 2025, our Director Harika G. led a session on Asia’s evolving energy mix.

At the Asian Power Summit 2025, our Director Harika G. led a session on Asia’s evolving energy mix.

Singapore Business Review featured Karambir Anand on Singapore’s expanding solar capacity and energy challenges.

Singapore Business Review featured Karambir Anand on Singapore’s expanding solar capacity and energy challenges.

Publications

The Current Energy Transition in Vietnam

Policy Ambitions Versus Reality – The Current Energy Transition in Vietnam

Vietnam is rapidly transitioning its energy system as power demand rises alongside industrial growth. While the government targets net-zero emissions by 2050, infrastructure, regulatory, and financing gaps slow progress. LNG, wind, and energy storage are key levers in the transition from coal to a greener energy mix.

AI in Healthcare Whitepaper

AI in Healthcare: Keeping the Patient at the Center of Innovation

AI is reshaping healthcare by improving efficiency, diagnostics, and personalized care amid rising costs and workforce shortages. Applications span prediction, telemedicine, diagnostics, and robotics across providers, insurers, and pharma. Long-term impact depends on responsible adoption, data quality, and strong governance.

CRDMO Whitepaper

India’s CRDMO Market: Building Momentum through Operational Excellence

India’s CRDMO market is growing rapidly, driven by China+1 strategies, funding access, and policy support. However, scale, cost pressure, and regulatory demands pose challenges. To compete globally, companies will depend on operational excellence, technology adoption, and building scalable, end-to-end capabilities.

Employee Wellness in the Age of Healthtech

Employee Wellness in the Age of Healthtech

Employee wellness is becoming a strategic priority as workforce expectations evolve. Health technology is shifting programs toward personalized, proactive solutions, particularly across Asia. While data, privacy, and ROI challenges remain, organizations that integrate technology with human-centered design can build more resilient workforces.

Meet Our Experts

Establish industry dominance with our experts and partners

Yuki Ishida

Yuki Ishida

Managing Partner

Nationality: Japanese

Region Coverage:

Asia, North America

Past Experience:

Goldman Sachs

Pilar Dieter

Pilar Dieter

Managing Partner

Nationality: American

Region Coverage:

Asia, North America

Past Experience:

Alaris Consulting

Shingo Kasumoto

Shingo Kasumoto

Managing Partner

Nationality: Japanese

Region Coverage:

Asia

Past Experience:

P&G

Takahiro Okawa

Takahiro Okawara

Managing Partner

Nationality: Japanese

Region Coverage:

Japan, Singapore, Thailand, Vietnam, Indonesia

Past Experience:

Accenture, Rakuten

Jatin Gulati

Jatin Gulati

Managing Partner

Nationality: Indian

Region Coverage:

Asia

Past Experience:

McKinsey & Company, Accenture Strategy

laurt fihey

Laurent Fihey

Partner

Nationality: French

Region Coverage:

Europe, Asia, Middle East, Africa, North America, South America

Past Experience:

Arthur Andersen, Advancy

nuttapan meethong

Nuttapan Meethong

Director

Nationality: Thai

Region Coverage:

Asia

Past Experience:

KPMG Thailand

chi ly

Chi Ly

Director

Nationality: Vietnamese

Region Coverage:

Asia

Past Experience:

KPMG, PwC

Talk to Our Pharmaceutical Commercial Experts

Arrange a session with our experts to explore how YCP can assist you in addressing your business challenges.

YCP Group is the leading professional firm in Asia empowering excellence through diverse expertise:

  • YCP 
  • YCP Auctus
  • YCP Consus